We are live on ! Find out more
TECH icon

Bio-Techne

297 hedge funds and large institutions have $4.72B invested in Bio-Techne in 2017 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 99 increasing their positions, 105 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

6% more capital invested

Capital invested by funds: $4.46B → $4.72B (+$256M)

2% more funds holding

Funds holding: 292297 (+5)

6% less repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 105

6.02% less ownership

Funds ownership: 394.86%388.84% (-6%)

19% less call options, than puts

Call options by funds: $557K | Put options by funds: $687K

Holders
297
Holders Change
+5
Holders Change %
+1.71%
% of All Funds
6.74%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
41
Increased
99
Reduced
105
Closed
35
Calls
$557K
Puts
$687K
Net Calls
-$130K
Net Calls Change
-$94K
Name Holding Trade Value Shares
Change
Change in
Stake
FP
126
Foundry Partners
Minnesota
$2.25M -$1.51M -47,624 -41%
Bank of Montreal
127
Bank of Montreal
Ontario, Canada
$2.13M +$950K +29,892 +84%
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
$2.07M
PAM
129
Palisade Asset Management
Minnesota
$2.06M -$191K -6,000 -9%
FIM
130
Freedom Investment Management
Connecticut
$1.95M +$57.4K +1,808 +3%
Federated Hermes
131
Federated Hermes
Pennsylvania
$1.94M -$289K -9,108 -13%
Balyasny Asset Management
132
Balyasny Asset Management
Illinois
$1.91M +$1.25M +39,332 +201%
VRS
133
Virginia Retirement Systems
Virginia
$1.9M -$458K -14,400 -20%
RAM
134
Redmond Asset Management
Virginia
$1.89M -$64.8K -2,040 -3%
T. Rowe Price Associates
135
T. Rowe Price Associates
Maryland
$1.86M -$269K -8,464 -13%
RJA
136
Raymond James & Associates
Florida
$1.83M +$39.4K +1,240 +2%
OPERF
137
Oregon Public Employees Retirement Fund
Oregon
$1.8M +$19.2K +604 +1%
TCM
138
Tributary Capital Management
Nebraska
$1.8M +$25.4K +800 +1%
SG Americas Securities
139
SG Americas Securities
New York
$1.77M +$1.74M +54,812 New
VOYA Investment Management
140
VOYA Investment Management
Georgia
$1.75M -$71.4K -2,248 -4%
SOMRS
141
State of Michigan Retirement System
Michigan
$1.75M -$63.5K -2,000 -4%
ZCA
142
Zeke Capital Advisors
Pennsylvania
$1.72M +$431K +13,580 +34%
GIP
143
Granite Investment Partners
California
$1.71M -$286K -8,996 -15%
Teacher Retirement System of Texas
144
Teacher Retirement System of Texas
Texas
$1.65M +$1.23M +38,680 +314%
MLICM
145
Metropolitan Life Insurance Company (MetLife)
New York
$1.61M -$3.1M -97,524 -66%
BG
146
Bahl & Gaynor
Ohio
$1.6M +$86.4K +2,720 +6%
CAPTRUST Financial Advisors
147
CAPTRUST Financial Advisors
North Carolina
$1.51M +$79.3K +2,496 +6%
OAM
148
Oppenheimer Asset Management
New York
$1.47M
MERSOM
149
Municipal Employees' Retirement System of Michigan
Michigan
$1.46M
UBS Group
150
UBS Group
Switzerland
$1.45M -$639K -20,124 -31%

TECH Hedge Fund Activity: Q4 2017 in Review

297 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2017, worth a combined $4.72B — up 5.7% from $4.46B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new TECH positions and 35 closed out — a net gain of 6 holders — while 99 added to existing stakes and 105 trimmed.

The largest buyer was TimesSquare Capital Management, opening a new position worth an estimated $44.2M. The largest seller was Select Equity Group, cutting an estimated $47M.

  • 297 institutional investors held Bio-Techne (TECH) as of Q4 2017, up from 292 in Q3 2017.
  • Funds reported $4.72B of Bio-Techne stock for Q4 2017, up 5.7% quarter-over-quarter.
  • 41 funds opened new Bio-Techne positions in Q4 2017 and 35 closed out, a net change of +6 holders.
  • The largest Bio-Techne buyer in Q4 2017 was TimesSquare Capital Management, an estimated $44.2M added.
  • The largest Bio-Techne seller in Q4 2017 was Select Equity Group, an estimated $47M sold.

Based on aggregated 13F filings for Q4 2017.